McKesson Corporation operates as a pharmaceutical distribution services and information technology company. Segments The company operates its business through two segments, McKesson Distribution Solutions and McKesson Technology Solutions. Distribution Solutions segment This segment distributes branded and generic pharmaceutical drugs and other healthcare-related products worldwide and provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. This segment also provides specialty pharmaceutical solutions for pharmaceutical manufacturers, including offering various distribution channels and clinical trial access to its network of oncology physicians. It also provides medical-surgical supply distribution, equipment, logistics and other services to healthcare providers within the United States. Additionally, this segment operates retail pharmacies in Europe and supports independent pharmacy networks within North America. It also sells financial, operational and clinical solutions to pharmacies (retail, hospital, alternate site) and provides consulting, outsourcing and other services. This segment consists of the businesses, including North America pharmaceutical distribution and services, International pharmaceutical distribution and services, and Medical-Surgical distribution and services. North America pharmaceutical distribution and services The company’s North America pharmaceutical distribution and services business is comprised of business units, such as U.S. Pharmaceutical Distribution, McKesson Specialty Health, McKesson Canada, and McKesson Pharmacy Technology & Services. U.S. Pharmaceutical Distribution: This business supplies branded, specialty and generic pharmaceuticals and other healthcare-related products to customers throughout the United States in three primary customer channels, which include retail national accounts (including national and regional chains, food/drug combinations, mail order pharmacies and mass merchandisers); independent retail pharmacies; and institutional healthcare providers (including hospitals, health systems, integrated delivery networks, clinics and alternate site providers). This business also provides solutions and services to pharmaceutical manufacturers. This business sources materials and products from an array of different suppliers, including certain generic pharmaceutical drugs produced through a contract-manufacturing program. The company’s U.S. pharmaceutical distribution business operates and serves various customer locations through a network of 31 distribution centers, as well as a primary redistribution center, a strategic redistribution center and two repackaging facilities, serving all 50 states and Puerto Rico. The major customer groups of the company’s U.S. Pharmaceutical Distribution business is categorized as retail national accounts, independent retail pharmacies and institutional healthcare providers. Retail National Accounts This includes business solutions that help national account customers increase revenues and profitability. Central Fill — Prescription refill service that enables pharmacies to refill prescriptions remotely, while reducing inventory levels and improving customer service. Redistribution Centers — Two facilities totaling approximately 750,000 square feet that offer access to inventory for single source warehouse purchasing, including pharmaceuticals and biologics. These distribution centers also provide the foundation for a two-tiered distribution network that supports direct store delivery. McKesson SynerGx — Generic pharmaceutical purchasing program and inventory management that helps pharmacies maximize their cost savings with a selection of generic drugs, competitive pricing and one-stop shopping. RxPak — Bulk-to-bottle repackaging service that leverages the company’s purchasing scale and supplier relationships to provide pharmaceuticals at reduced prices, help increase inventory turns and reduce working capital investment. Inventory Management — An integrated solution comprising forecasting software and au
mckesson corp (MCK:New York)
One Post Street
San Francisco, CA 94104
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for MCK.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact MCKESSON CORP, please visit www.mckesson.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.